Obesity is a multifactorial, chronic disorder that has reached epidemic proportions in most industrialized countries and is threatening to become a global epidemic. Obese patients are at higher risk from coronary artery disease, hypertension, hyperlipidemia, diabetes mellitus, cancers, cerebrovascular accidents, osteoarthritis, restrictive pulmonary disease, and sleep apnoea. In particular, visceral fat accumulation is usually accompanied by insulin resistance or type 2 diabetes mellitus, hypertension, hypertriglyceridemia, high uremic acid levels, low high density lipoprotein (HDL) cholesterol to define a variously named syndrome or metabolic syndrome. Metabolic syndrome is now considered a major cardiovascular risk factor in a large percentage of population in worldwide. Both obesity and metabolic syndrome are particularly challenging clinical conditions to treat because of their complex pathophysiological basis. Indeed, body weight represents the integration of many biological and environmental components and relationships among fat and glucose tolerance or blood pressure are not completely understood. Efforts to develop innovative anti-obesity drugs, with benefits for metabolic syndrome, have been recently intensified. In general two distinct strategies can be adopted: first, to reduce energy intake; second, to increase energy expenditure. Here we review some among the most promising avenues in these two fields of drug therapy of obesity and, consequently, of metabolic syndrome.
Emerging aspects of pharmacotherapy for obesity and metabolic syndrome / E. Nisoli, M.O. Carruba. - In: PHARMACOLOGICAL RESEARCH. - ISSN 1043-6618. - 50:5(2004 Nov), pp. 453-469.
|Titolo:||Emerging aspects of pharmacotherapy for obesity and metabolic syndrome|
NISOLI, ENZO (Primo)
CARRUBA, MICHELE (Ultimo)
|Parole Chiave:||Anti-obesity drugs; Leptin; Metabolic fitness; Metabolic syndrome; Mitochondria; Obesity; Obesity-related disorders; Thermogenic drugs|
|Settore Scientifico Disciplinare:||Settore BIO/14 - Farmacologia|
|Data di pubblicazione:||nov-2004|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1016/j.phrs.2004.02.004|
|Appare nelle tipologie:||01 - Articolo su periodico|